cytarabine has been researched along with Preleukemia in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (73.68) | 18.7374 |
| 1990's | 10 (26.32) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abidi, SM; Copplestone, A; Hamblin, TJ; Mufti, GT; Oscier, DG | 1 |
| Baccarani, M; Bandini, G; Cavazzini, G; Fanin, R; Tura, S; Zaccaria, A | 1 |
| Christensson, B; Engsted, L; Gyllenhammar, H; Lindström, P; Ost, A | 1 |
| Dan, K; Gomi, S; Horikoshi, H; Kuwabara, T; Nomura, T; Ogata, K; Ohki, I | 1 |
| Griffin, JD; Kufe, DW; Wisch, JS | 1 |
| Stuart, J | 1 |
| Blank, J; Lange, B | 1 |
| Jehn, U | 1 |
| Champlin, R; Gajewski, J; Ho, W; Lee, M; Schiller, G; Territo, M | 1 |
| Digel, W; Kunzmann, R; Lindemann, A; Mertelsmann, R; Schultze, J | 1 |
| Preisler, H | 1 |
| Lee, M; Schiller, G | 1 |
| Hagiwara, S; Hirano, N; Miwa, A; Takezako, N; Togawa, A; Yuo, A | 1 |
| Mollee, PN; Rodwell, R; Taylor, D; Taylor, KM; Williams, B | 1 |
| Gale, RP | 1 |
| Najean, Y; Pecking, A | 1 |
| Carbone, TV; Kelleher, JF | 1 |
| Berglund, G; Gustafsson, G; Jonmundsson, G; Lie, SO; Siimes, M; Yssing, M | 1 |
| Aul, C; Schneider, W | 1 |
| Uchino, H; Yamagishi, M; Yoshida, Y | 1 |
| Abe, T; Fujii, H; Horiike, S; Inazawa, J; Misawa, S; Nakagawa, H; Sonoda, Y; Tanaka, S; Taniwaki, M; Tsuda, S | 1 |
| Champlin, RE; Gajewski, JL; Gekelman, L; Hirji, KF; Ho, WG; Jacobs, AD; Nimer, SD | 1 |
| Miyazaki, T; Morioka, M; Sakurada, K | 1 |
| Nakada, H; Takahashi, I | 1 |
| Lazarus, AA; McMillan, M; Miramadi, A | 1 |
| Azarnia, N; Barcos, M; Browman, G; D'Arrigo, P; Grunwald, H; Larson, R; Preisler, HD; Raza, A; Stein, A; Walker, I | 1 |
| Kufe, DW; Spriggs, DR; Stone, RM | 1 |
| Griffin, J; Kufe, DW; Sokal, JE; Spriggs, DR | 1 |
| Gaynor, ER; Larson, RA; Miller, KB; Variakojis, D; Winter, JN | 1 |
| Allen, S; Budman, DR; Chan, K; Chaudhri, F; Deere, M; Freeman, J; Kreis, W; Schulman, P; Vinciguerra, V; Weiselberg, L | 1 |
| Berney, JJ; Francis, GE; Guimaraes, JE; Wing, MA | 1 |
| Griffin, JD; Kufe, DW; Spriggs, DR | 1 |
| Griffin, J; Kufe, D; Spriggs, D; Wisch, J | 1 |
| Larson, RA | 1 |
| Griffin, JD; Kufe, DW; Spriggs, D; Wisch, JS | 1 |
| Alessandrino, EP; Bernasconi, C; Bertazzoni, U; Brusamolino, E; Isernia, P; Scovassi, AI | 1 |
| Alessandrino, EP; Bernasconi, C; Brusamolino, E; Lazzarino, M; Orlandi, E | 1 |
5 review(s) available for cytarabine and Preleukemia
| Article | Year |
|---|---|
Poor prognosis acute myelogenous leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Cell Division; Cytarabine; Daunorubicin; Drug Resistance; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Neoplasms, Second Primary; Neoplastic Stem Cells; Preleukemia; Prognosis; Recombinant Proteins; Remission Induction; Retrospective Studies; Risk Factors; Salvage Therapy; Survival Analysis; Treatment Failure | 1993 |
Advances in the treatment of acute myelogenous leukemia.
Topics: Antineoplastic Agents; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Drug Therapy, Combination; Hemorrhage; Humans; Immunotherapy; Infections; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Meningeal Neoplasms; Preleukemia; Prognosis; Remission, Spontaneous; Transplantation, Homologous | 1979 |
Monosomy 7 syndrome in an infant with neurofibromatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosomes, Human, Pair 7; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Etoposide; Humans; Infant; Leukemia, Myelomonocytic, Chronic; Male; Monocytes; Monosomy; Neurofibromatosis 1; Pedigree; Preleukemia; Syndrome; Thioguanine | 1991 |
The treatment of myelodysplastic syndromes.
Topics: Adult; Aged; Antineoplastic Agents; Blood Transfusion; Bone Marrow Transplantation; Cytarabine; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Middle Aged; Myelodysplastic Syndromes; Preleukemia; Prognosis | 1986 |
Cellular and clinical pharmacology of low-dose ara-C.
Topics: Adult; Aged; Aphidicolin; Bone Marrow; Cell Differentiation; Cell Division; Cell Line; Cytarabine; Diterpenes; DNA; DNA Replication; Dose-Response Relationship, Drug; Female; Hemoglobins; Humans; Karyotyping; Kinetics; Leukemia; Male; Middle Aged; Preleukemia | 1985 |
6 trial(s) available for cytarabine and Preleukemia
| Article | Year |
|---|---|
Chemotherapy of the myeloid leukaemias.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Busulfan; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Preleukemia; Remission, Spontaneous; Thioguanine | 1980 |
Long-term outcome of postremission chemotherapy for adults with acute myeloid leukemia using different dose-intensities.
Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Germany; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Opportunistic Infections; Patient Acceptance of Health Care; Preleukemia; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vincristine | 1994 |
Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for older patients with acute myelogenous leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Preleukemia; Prognosis; Risk Factors; Treatment Outcome | 1997 |
Refractory anemia with excess of blast cells: prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients. Cooperative Group for the Study of Aplastic and Refractory Anemias.
Topics: Acute Disease; Adult; Aged; Anemia, Aplastic; Bone Marrow; Clinical Trials as Topic; Cytarabine; Female; Humans; Leukemia; Male; Middle Aged; Preleukemia; Prognosis; Testosterone Congeners | 1979 |
High-dose Ara-C as a single-agent consolidation therapy in childhood acute myelogenous leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Cross-Sectional Studies; Cytarabine; Down Syndrome; Doxorubicin; Humans; Iceland; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Life Tables; Multicenter Studies as Topic; Preleukemia; Remission Induction; Scandinavian and Nordic Countries; Survival Rate; Thioguanine | 1990 |
High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup study.
Topics: Adult; Aged; Clinical Trials as Topic; Cytarabine; Drug Administration Schedule; Humans; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Platelet Count; Preleukemia; Thrombocytopenia | 1986 |
27 other study(ies) available for cytarabine and Preleukemia
| Article | Year |
|---|---|
Treatment for pre-leukaemia?
Topics: Cell Differentiation; Cytarabine; Humans; Preleukemia | 1984 |
Cytarabine in pre-leukaemia.
Topics: Aged; Cytarabine; Humans; Preleukemia | 1984 |
Low dose arabinosyl cytosine for treatment of myelodysplastic syndromes and subacute myeloid leukemia.
Topics: Adult; Aged; Anemia; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Myeloproliferative Disorders; Preleukemia | 1983 |
Acute leukaemia in a defined geographic area--incidence, clinical history and prognosis.
Topics: Adolescent; Adult; Age Factors; Aged; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisolone; Preleukemia; Sweden; Thioguanine; Vincristine | 1984 |
[Small-dose cytarabine (Ara-C) in the treatment of myelodysplastic syndrome].
Topics: Anemia, Aplastic; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Preleukemia | 1984 |
Response of preleukemic syndromes to continuous infusion of low-dose cytarabine.
Topics: Adult; Aged; Blood Cell Count; Bone Marrow; Cytarabine; Evaluation Studies as Topic; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Preleukemia; Syndrome | 1983 |
Preleukemia in children.
Topics: Adolescent; Blood Cell Count; Bone Marrow Cells; Child; Child, Preschool; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Male; Preleukemia | 1981 |
Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; California; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Mitoxantrone; Preleukemia; Remission Induction; Survival Analysis; Thioguanine; Treatment Outcome | 1994 |
Poor prognosis of prethymic phenotype acute lymphoblastic leukemia (pre-T-ALL).
Topics: Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; B-Lymphocytes; Cyclophosphamide; Cytarabine; Daunorubicin; Follow-Up Studies; Humans; Immunophenotyping; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Prednisone; Preleukemia; Prognosis; Remission Induction; T-Lymphocytes; Time Factors; Vincristine | 1994 |
A rare atypical myeloproliferative-disorder-like hemopathy with marked dysplasia, peripheral dominant myeloblast proliferation and extramedullary hematopoiesis was converted into typical acute myeloid leukemia with an interval of complete hematological re
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Daunorubicin; Disease Progression; Hematopoiesis, Extramedullary; Humans; Leukemia, Myeloid; Male; Mercaptopurine; Middle Aged; Myelodysplastic Syndromes; Myeloproliferative Disorders; Prednisolone; Preleukemia; Remission Induction | 1998 |
Long-term molecular remission in promyelocytic transformation of myeloproliferative disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Female; Humans; Idarubicin; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Polycythemia Vera; Preleukemia; Prognosis; Remission Induction; Thrombocythemia, Essential; Thrombophilia; Translocation, Genetic; Tretinoin | 1999 |
Treatment of advanced myelodysplastic syndromes: trend toward more aggressive chemotherapy?
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Evaluation; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Preleukemia; Remission Induction; Thioguanine | 1990 |
[Definition, diagnosis and treatment of preleukemic syndrome].
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Humans; Preleukemia | 1989 |
[Relation of karyotypic findings to chemotherapy response in patients with preleukemia].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Chromosome Aberrations; Chromosomes, Human, Pair 5; Chromosomes, Human, Pair 7; Cytarabine; Female; Humans; Male; Middle Aged; Myelodysplastic Syndromes; Preleukemia | 1989 |
Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.
Topics: Age Factors; Anemia, Aplastic; Anemia, Refractory, with Excess of Blasts; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Multivariate Analysis; Neural Tube Defects; Preleukemia; Prognosis; Regression Analysis; Survival Rate; Thioguanine | 1989 |
[Therapy of the preleukemic state: effect of androgens on refractory anemia].
Topics: Adult; Aged; Androgens; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Blast Crisis; Cholecalciferol; Chromosome Aberrations; Cytarabine; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Preleukemia; Prognosis | 1988 |
[Chemotherapeutic effects in hypoplastic leukemia].
Topics: Adult; Aged; Antineoplastic Agents; Cytarabine; Drug Evaluation; Humans; Immunoglobulin G; Immunotoxins; Infusions, Intravenous; Leukemia, Myeloid, Acute; Melphalan; Middle Aged; Preleukemia | 1988 |
Pulmonary involvement in Sweet's syndrome (acute febrile neutrophilic dermatosis). Preleukemic and leukemic phases of acute myelogenous leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Dermatitis; Fever; Humans; Leukemia, Myeloid; Male; Middle Aged; Neutrophils; Pneumonia; Prednisone; Preleukemia; Radiography; Syndrome | 1986 |
Low dose ara-C administered by continuous subcutaneous infusion: a pharmacologic evaluation.
Topics: Adult; Aged; Cytarabine; Humans; Leukemia; Male; Middle Aged; Preleukemia | 1986 |
Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemia.
Topics: Acute Disease; Adult; Aged; Bone Marrow; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Injections, Subcutaneous; Leukemia; Leukemia, Myeloid; Male; Middle Aged; Preleukemia | 1985 |
Pharmacokinetics of low-dose 1-beta-D-arabinofuranosylcytosine given by continuous intravenous infusion over twenty-one days.
Topics: Aged; Cytarabine; Female; Humans; Injections, Intravenous; Kinetics; Leukemia, Myeloid, Acute; Male; Middle Aged; Preleukemia | 1985 |
Synergistic interaction between differentiation inducers and DNA synthesis inhibitors: a new approach to differentiation induction in myelodysplasia and acute myeloid leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Aphidicolin; Bone Marrow; Bone Marrow Diseases; Cell Differentiation; Cells, Cultured; Cytarabine; Diterpenes; DNA; Drug Synergism; Formamides; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Preleukemia; Syndrome; Tretinoin | 1985 |
Clinical pharmacology of low-dose cytosine arabinoside.
Topics: Acute Disease; Cytarabine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Infusions, Parenteral; Leukemia; Preleukemia; Radioimmunoassay | 1985 |
Management of myelodysplastic syndromes.
Topics: Antineoplastic Agents; Bone Marrow Diseases; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Humans; Preleukemia | 1985 |
Treatment of preleukemic syndromes with continuous intravenous infusion of low-dose cytosine arabinoside.
Topics: Adult; Aged; Bone Marrow; Chromosome Aberrations; Colony-Forming Units Assay; Cytarabine; Drug Evaluation; Female; Hematopoiesis; Humans; Infusions, Parenteral; Male; Middle Aged; Preleukemia; Syndrome; Time Factors | 1985 |
Terminal deoxynucleotidyl transferase-positive acute leukemias evolving from a myelodysplastic syndrome.
Topics: Acute Disease; Adult; Cytarabine; DNA Nucleotidylexotransferase; DNA Nucleotidyltransferases; Humans; Leukemia; Myeloproliferative Disorders; Preleukemia | 1985 |
Low-dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia.
Topics: Acute Disease; Adult; Aged; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia; Middle Aged; Myeloproliferative Disorders; Preleukemia | 1985 |